FTC sues important pharmacy gain managers in excess of insulin charges The agency brought action in opposition to Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the record cost of lifetime-conserving insulin prescription drugs. Sanders swiftly condemned the transfer in an announcement Wednesday, https://buschlightpeachcalories15059.bluxeblog.com/62740506/details-fiction-and-healthcare-news